CompletedNot Applicable

Impacts of an Advanced Practice Physiotherapy Model of Care for Adults With a Peripheral Musculoskeletal Disorders Referred to an Orthropaedic Outpatient Clinic

Canada104 participantsStarted 2022-11-15

Plain-language summary

The goal of this prospective observational study is to evaluate advanced practice physiotherapy and orthopedic surgeon care and clinical outcomes for new patients with a peripheral musculoskeletal disorders consulting at the orthopedic outpatient clinic of the Hôpital Jean-Talon. The main questions it aims to answer are: 1. To describe the models of care at the Hôpital Jean-Talon orthopedic outpatient clinic; 2. To assess change in pain, disability, quality of life and pain catastrophizing at 6, 12 and 26 weeks after the initial evaluation; 3. To assess interprofessional collaboration between the advanced practice physiotherapists and orthopedic surgeons; 4. To assess patient satisfaction with care; 5. To assess waiting time before an initial consultation. Researchers will compare patients cared in the advanced practice physiotherapy and orthopedic surgeon group and the orthopedic surgeon only group.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults with peripheral musculoskeletal disorders * New consultation at the Hôpital Jean-Talon orthopedic outpatient clinic * Legally able to consent * Understand and speak French or English * Beneficiaries of the provincial universal health insurance coverage (RAMQ) Exclusion Criteria: * Patients directly referred from the emergency department (not considered as patients referred to the outpatient clinic).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Brief pain inventory severity

Timeframe: 6 weeks (change from baseline)

Brief pain inventory severity

Timeframe: 12 weeks (change from baseline)

Brief pain inventory severity

Timeframe: 26 weeks (change from baseline)

Brief pain inventory inventory

Timeframe: 6 weeks (change from baseline)

Brief pain inventory inventory

Timeframe: 12 weeks (change from baseline)

Brief pain inventory inventory

Timeframe: 26 weeks (change from baseline)

Trial details

NCT IDNCT05714332

SponsorCiusss de L'Est de l'Île de Montréal

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-01-02

View on ClinicalTrials.gov More Musculoskeletal Disorders trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Brief pain inventory severity

Timeframe: 6 weeks (change from baseline)

Brief pain inventory severity

Timeframe: 12 weeks (change from baseline)

Brief pain inventory severity

Timeframe: 26 weeks (change from baseline)

Brief pain inventory inventory

Timeframe: 6 weeks (change from baseline)

Brief pain inventory inventory

Timeframe: 12 weeks (change from baseline)

Brief pain inventory inventory

Timeframe: 26 weeks (change from baseline)